BioSpace News Archive

Drug Development

Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

Angel Pharmaceuticals Ltd. (“Angel Pharma”), a clinical-stage biopharmaceutical company, today announced that the IND application for mupadolimab (formerly CPI-006) has been approved by the Center for Drug Evaluation (CDE) to initiate a Phase 1/1b clinical trial in China.

September 26, 2022
·
3 min read
Rise in Head and Neck Cancer Incidences Across the Globe is Expected to Drive Head and Neck Squamous Cell Carcinoma Treatment Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Head and Neck Squamous Cell Carcinoma Treatment Market – Forecast to 2030,’ thoroughly examines the Head and Neck Squamous Cell Carcinoma Treatment industry to provide essential data & information for the targeted readers.

September 26, 2022
·
6 min read
Increasing Pre-Disposition to Obesity, Radiation Exposure during Childhood is Expected to Drive Inflammatory Breast Cancer Treatment Market Growth by 2030

The latest market analysis report published by Reports and Data, titled ‘Global Inflammatory Breast Cancer Treatment Market – Forecast to 2030,’ thoroughly examines the Inflammatory Breast Cancer Treatment industry to provide essential data & information for the targeted readers.

September 26, 2022
·
6 min read
Rising Prevalence of Urea Cycle Disorders is Expected to Drive Urea Cycle Disorder Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Urea Cycle Disorder Market – Forecast to 2030,’ thoroughly examines the Urea Cycle Disorder industry to provide essential data & information for the targeted readers.

September 26, 2022
·
6 min read
Bioscience Association Manitoba Celebrates Global Biotech Week 2022

Today marks the beginning of Global Biotech Week which aims to increase awareness of Manitoba’s $10.4 billion biotech industry, its global potential, policymakers, influencers, and the public.

September 26, 2022
·
1 min read